mPEG36-NH2

mPEG36-NH2
Product Description

mPEG36-Amine is a linear methoxy PEG reagent with reactive amine (NH2) group that react rapidly with activated carboxylic acids such as NHS esters to form stable amide bonds. Amines can also react with carbonyl groups, such as ketones and aldehydes.
mPEG36-NH2 is potentially useful in numerous applications. Such applications include the following:

  • Act as a linker for Antibody-Drug Conjugates (ADCs), improving the drug's solubility and stability;
  • Passivates nanoparticle surfaces, including those of carbon nanotubes and graphene oxide;
  • Creates a non-immune "stealth" coating for liposomes and micelles;
  • Increase the hydrodynamic volume of small molecules, including peptides and antibody fragments;
  • Increases the water solubility of hydrophobic molecules.
  • Hunan HuaTeng Pharmaceutical Co., Ltd.

    • Country/Region:
      China
    • On CPHI since:
      2015
    • Certificates:
      1
    • Employees:
      250 - 499
    Company types
    CMO/CDMO
    Manufacturer/Innovator
    Primary activities
    Contract Manufacturer
    Custom Manufacturing/Custom Synthesis
    Fine Chemicals Company
    Intermediates Manufacturer
    Specifications
    • CAS Registry Number
      32130-27-1
    • Supplied from
      China

    Hunan HuaTeng Pharmaceutical Co., Ltd.

    • Country/Region:
      China
    • On CPHI since:
      2015
    • Certificates:
      1
    • Employees:
      250 - 499
    Company types
    CMO/CDMO
    Manufacturer/Innovator
    Primary activities
    Contract Manufacturer
    Custom Manufacturing/Custom Synthesis
    Fine Chemicals Company
    Intermediates Manufacturer

    More Products from Hunan HuaTeng Pharmaceutical Co., Ltd. (4)

    • Cholesterol (Plant-Derived) CAS NO.: 57-88-5

      Product Cholesterol (Plant-Derived) CAS NO.: 57-88-5

      Plant-derived cholesterol, as a new type of pharmaceutical excipient, can be used as helper lipids in lipid nanoparticle (LNP) formulations as it enhances particle stability by regulating membrane integrity and rigidity. Traditionally, cholesterol has been derived from eggs or animal sources. However, t...
    • mPEG-pALD

      Product mPEG-pALD

      Applicated in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound.
    • N3-PEG11-NH2

      Product N3-PEG11-NH2

      Azido-PEG11-amine (CAS No. 1800414-71-4) is a monodispersed PEG derivative containing an amino group with an azide group.  The azide group can react with alkyne, BCN, DBCO via Click Chemistry to yield a stable triazole linkage.  The amino group is reactive with carboxylic acids, activat...
    • Pharmaceutical Intermediates

      Product Pharmaceutical Intermediates

      Huateng Pharma is expert in manufacturing and development of pharmaceutical intermediates in its ultra-modern state of art facilities located at Changsha, China.
      We can provide the following pharmaceutical intermediates. Please inquire at [email protected] about pricing and availability.&...

    Hunan HuaTeng Pharmaceutical Co., Ltd. resources (3)

    • News What Are PEG Linkers and Their Applications?

      Learn more detailes about PEG linkers and its applications in pharmaceutical field.
    • Brochure Huateng Pharma Product Catalog

      Hunan Huateng Pharmaceutical Co., Ltd is a world-leading supplier of PEG derivatives and CDMO for APIs and intermediates from R&D lab supply to commercial production.
    • Brochure Huateng Pharma Company Introduction

      Hunan Huateng Pharmaceutical Co., Ltd. is a world-leading supplier of PEG derivatives and CDMO for APIs and intermediates from R&D lab supply to commercial production. We provide comprehensive support for bio-pharmaceutical industry with our PEGs technology. And we also provide tailor made raw materials solution for chemical pharmaceutical industry with our state-of-the-art CDMO capabilities.